Previous close | 552.39 |
Open | 551.45 |
Bid | 0.00 x 800 |
Ask | 0.00 x 900 |
Day's range | 548.81 - 560.68 |
52-week range | 373.28 - 566.16 |
Volume | |
Avg. volume | 676,435 |
Market cap | 72.452B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 24.87 |
EPS (TTM) | 22.41 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.48 (0.44%) |
Ex-dividend date | 03 Jun 2024 |
1y target est | 595.69 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors in McKesson Corporation ( NYSE:MCK ) had a good week, as its shares rose 2.4% to close at US$544 following...